Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1794

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 4
Chunk 1794
---
 known and unknown risks, uncertainties, and other factors that may cause the actual results,
performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by
these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these
forward-looking statements can be found elsewhere in this Report and in our periodic reports filed with the U.S. Securities and Exchange
Commission. The forward-looking statements included are made only as of the date of this report. Except as required by law, we have no
obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the
date of the report.

Overview

We
operate a diversified financial technology services company offering multiple business units across key sectors, including a financial
education division offering tools, products and content through a global network of independent distributors; a manufacturing division
focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets,
with strategic plans for global expansion; an early-stage online trading platform that intends to offer self-directed retail brokerage
services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

26

Recent
Material Developments

Private
Share Repurchase Transactions

We
have attempted to repurchase shares privately, when the circumstances arise, as an opportunistic way to use our existing cash resources
strategically to add shareholder value by significantly reducing our outstanding capitalization at a discounted price to the market.
These opportunities have arisen for us on three occasions. First, on September 29, 2023, we purchased for surrender in a series of private
transactions, an aggregate of 302,919,223 shares of the Company’s common stock from two of our former Directors and executive officers,
and a series of their family members and related entities. The shares were purchased for an aggregate consideration of $2,922,380, equating
to a price of $0.00964739 per share; representing a discount of approximately 52.5% to the average market price at the time of closing.
One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly
payments over seven (7) consecutive quarters thereafter. See Item 13 of this Form 10-K for additional details on the transaction.

Next,
further private purchases were effectuated on February 7, 2024, when we repurchased